Fri.Aug 30, 2024

article thumbnail

Vaccines: Saving Lives and Money for Over 200 Years

Science Based Medicine

Vaccines save lives and money according to a recently published CDC report. This shouldn't come as a surprise, but it's still nice to see. The post Vaccines: Saving Lives and Money for Over 200 Years first appeared on Science-Based Medicine.

CDC 112
article thumbnail

Friday Reflection 43: The Absence of Reassuring Counterfactuals in Clinical Medicine

Sensible Medicine

KN is a 90-year-old man I visit at an inpatient hospice. His son warned me that my visit might “be a waste of time” because he sleeps much of the day and “can’t even get out of bed.” When I arrive, however, I find him in good spirits. He is pain free, cognitively intact, and genuinely pleased to see me. He is not only happy for the company but touched that I made the effort to come.

Hospice 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

SAEM Clinical Images Series: Pediatric Neck Mass

ALiEM

A 5-year-old female presented to the emergency department (ED) with a one-year history of gradually increasing anterior neck swelling. The patient had no significant past medical history. She also endorsed three weeks of cough and congestion, and one day of muffled voice. She denied difficulty swallowing, fatigue, cold intolerance, or hair and nail changes.

article thumbnail

Wegovy reduced deaths from Covid-19

PulmCCM

In the SELECT trial , semaglutide (Wegovy and Ozempic’s active ingredient) reduced cardiovascular death and all-cause mortality among 17,604 enrolled patients—a momentous finding that revealed the drug’s potential not just for weight loss, but for control of chronic diseases associated with obesity. But wait, there’s more.

52
article thumbnail

Tranexamic acid for GI bleeds: Review

PulmCCM

Tranexamic acid (TXA) is a synthetically produced derivative of the amino acid lysine. TXA reversibly binds to plasminogen, reducing its fibrinolytic action. TXA’s FDA indications are limited to the prevention of heavy bleeding during tooth extraction in patients with hemophilia, and also for heavy menstrual bleeding.

52